Clinical Trials Market Size & Share Report, 2025 – 2034

Clinical Trials Market – By Phase, By Study Design, By Therapeutic Area, By Service Type – Global Forecast 2025 – 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing prevalence of chronic diseases across the globe

3.2.1.2&nbsp;&nbsp;&nbsp; Growing demand for outsourcing clinical trials to CROs

3.2.1.3&nbsp;&nbsp;&nbsp; Rise in government and non-government funding for clinical trials

3.2.1.4&nbsp;&nbsp;&nbsp; Growing opportunities for conducting clinical trials in countries of Asia Pacific

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Lack of skilled workforce in clinical research

3.2.2.2&nbsp;&nbsp;&nbsp; Infrastructural barriers in developing countries

3.2.2.3&nbsp;&nbsp;&nbsp; Challenges faced in North America and Europe for conducting clinical trials

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Clinical trials volume analysis

3.4.1&nbsp;&nbsp;&nbsp; Clinical trials volume analysis, by region, 2021 - 2024

3.4.2&nbsp;&nbsp;&nbsp; Clinical trials volume analysis, by phase of development, 2021 - 2024

3.4.3&nbsp;&nbsp;&nbsp; Clinical trials volume analysis, by indication, 2021 - 2024

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.5.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5.3.1&nbsp;&nbsp;&nbsp; Singapore

3.5.3.2&nbsp;&nbsp;&nbsp; Malaysia

3.5.3.3&nbsp;&nbsp;&nbsp; Indonesia

3.5.3.4&nbsp;&nbsp;&nbsp; Thailand

3.5.3.5&nbsp;&nbsp;&nbsp; South Korea

3.5.3.6&nbsp;&nbsp;&nbsp; Philippines

3.6&nbsp;&nbsp;&nbsp; Clinical trials - Asia Pacific advantage

3.7&nbsp;&nbsp;&nbsp; Porters analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Merger and acquisition landscape

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Phase, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Phase I

5.3&nbsp;&nbsp;&nbsp; Phase II

5.4&nbsp;&nbsp;&nbsp; Phase III

5.5&nbsp;&nbsp;&nbsp; Phase IV

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Study Design, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Interventional study

6.3&nbsp;&nbsp;&nbsp; Observational study

6.4&nbsp;&nbsp;&nbsp; Expanded access study

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Service Type, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Outsourcing service

7.3&nbsp;&nbsp;&nbsp; In-house service

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Therapeutic Area, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Autoimmune disease

8.3&nbsp;&nbsp;&nbsp; Oncology

8.4&nbsp;&nbsp;&nbsp; Cardiology

8.5&nbsp;&nbsp;&nbsp; Infectious disease

8.6&nbsp;&nbsp;&nbsp; Dermatology

8.7&nbsp;&nbsp;&nbsp; Ophthalmology

8.8&nbsp;&nbsp;&nbsp; Neurology

8.9&nbsp;&nbsp;&nbsp; Hematology

8.10&nbsp;&nbsp;&nbsp; Other therapeutic areas

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Poland

9.3.7&nbsp;&nbsp;&nbsp; Netherlands

9.3.8&nbsp;&nbsp;&nbsp; Switzerland

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Singapore

9.4.7&nbsp;&nbsp;&nbsp; Malaysia

9.4.8&nbsp;&nbsp;&nbsp; Indonesia

9.4.9&nbsp;&nbsp;&nbsp; Thailand

9.4.10&nbsp;&nbsp;&nbsp;Philippines

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp; South Africa

9.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Charles River Laboratories

10.2&nbsp;&nbsp;&nbsp; Clinipace

10.3&nbsp;&nbsp;&nbsp; Eli Lilly and Company

10.4&nbsp;&nbsp;&nbsp; ICON

10.5&nbsp;&nbsp;&nbsp; IQVIA

10.6&nbsp;&nbsp;&nbsp; Laboratory Corporation of America Holdings (Covance Inc)

10.7&nbsp;&nbsp;&nbsp; Medpace

10.8&nbsp;&nbsp;&nbsp; Merck &amp; Co

10.9&nbsp;&nbsp;&nbsp; Parexel International Corporation

10.10&nbsp;&nbsp;&nbsp; Pfizer

10.11&nbsp;&nbsp;&nbsp; SGS SA

10.12&nbsp;&nbsp;&nbsp; Syneos Health

10.13&nbsp;&nbsp;&nbsp; The Emmes Company

10.14&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific (PPD)

10.15&nbsp;&nbsp;&nbsp; Veeda Clinical Research

10.16&nbsp;&nbsp;&nbsp; Worldwide Clinical Trials

10.17&nbsp;&nbsp;&nbsp; WuXi AppTech 
&nbsp;

Clinical Trials Market

Request Discount

Industries

Information

Link

Global Headquarters